BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4357685)

  • 21. Detection of cellular hypersensitivity among multiple sclerosis (MS) patients to 6/94 virus; a parainfluenza type 1 isolate from MS brain tissue.
    Rauch HC; King KM; Lewandowski LJ
    Int Arch Allergy Appl Immunol; 1975; 48(4):475-84. PubMed ID: 164416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the immune response in multiple sclerosis and other inflammatory diseases of the central nervous system.
    Kinnman J
    Acta Neurol Scand Suppl; 1981; 81():1-96. PubMed ID: 6939210
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of measles virus antigen on leukocyte migration in multiple sclerosis and controls.
    Kinnman J; Link H; Möller E; Norrby E
    Acta Neurol Scand; 1978 Nov; 58(5):261-71. PubMed ID: 216219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular immunity to encephalitogenic protein in multiple sclerosis. Correlations with other laboratory characteristics at different disease courses.
    Nilsson O; Thelin C
    Eur Neurol; 1977; 16(1-6):247-56. PubMed ID: 79488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virus specific antibodies in multiple sclerosis.
    Fraser KB; Haire M; Millar JH
    Br Med J; 1972 Aug; 3(5824):471. PubMed ID: 4341646
    [No Abstract]   [Full Text] [Related]  

  • 26. Virological studies with multiple-sclerosis brain tissues.
    Barbosa LH; Hamilton R
    Lancet; 1973 Jun; 1(7817):1415-7. PubMed ID: 4122985
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
    Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF
    Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Lymphocyte transformation in vitro to paramyxovirus antigens in multiple sclerosis.
    Cunningham-Rundles S; Dupont B; Posner JB; Hansen JA; Good RA
    Lancet; 1975 Dec; 2(7946):1204. PubMed ID: 53681
    [No Abstract]   [Full Text] [Related]  

  • 29. [Humoral and cellular immunity to selected viral antigens in children from the Bełchatów Industrial Region].
    Stempień R; Słowińska I; Wardecka J; Deroń Z; Imbs D; Jankowski M; Jarzabek Z; Kańtoch M
    Med Dosw Mikrobiol; 1983; 35(3-4):259-68. PubMed ID: 6676608
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in immune response during responses in MS patients.
    Detels R; Myers LW; Ellison GW; Visscher BR; Malmgren RM; Madden DL; Sever JL
    Neurology; 1981 Apr; 31(4):492-5. PubMed ID: 6452588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal synthesis of virus antibodies: a diagnostic test for multiple sclerosis.
    Schädlich HJ; Mohrmann G; Nekic M; Felgenhauer K
    Eur Neurol; 1990; 30(5):302-4. PubMed ID: 2269323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of complement-fixation-reaction and hemagglutination-inhibition-test in measles of MS patients.
    Schorre E
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:121-4. PubMed ID: 4313659
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigation on the role of viral antibodies in the pathogenesis of multiple sclerosis.
    Matveeva TV; Pille ER; Diakonova IN; Andreeva AP
    Acta Virol; 1980 Dec; 24(6):415-20. PubMed ID: 6111202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles virus-induced migration inhibition of human leukocytes in vitro: an expression of cell-mediated immunity?
    Nordal HJ; Froland SS; Vandvik B; Norrby E
    Scand J Immunol; 1976; 5(8):969-77. PubMed ID: 996451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles and other virus-specific immunoglobulins in multiple sclerosis.
    Haire M; Fraser KB; Millar JH
    Br Med J; 1973 Sep; 3(5881):612-5. PubMed ID: 4356870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus antibody titers in multiple sclerosis patients, siblings, and controls.
    Brody JA; Sever JL; Henson TE
    JAMA; 1971 May; 216(9):1441-6. PubMed ID: 4325395
    [No Abstract]   [Full Text] [Related]  

  • 37. [The determination of viral antibodies in patients with disseminated sclerosis].
    Chaplygina NM; Bogomolova NN; Koptiaeva IB; Desiatskova RG; Zavalishin IA; Adarcheva LS; Timirbaeva SL; Ivanova-Smolenskaia IA; Iakovleva LS; Morozov VA
    Vopr Virusol; 1990; 35(3):240-1. PubMed ID: 2219859
    [No Abstract]   [Full Text] [Related]  

  • 38. The relationship between direct migration inhibition with measles antigen and E rosettes in normals and patients with multiple sclerosis.
    Utermohlen V; Farmer J; Kornbluth J; Kornstein M
    Clin Immunol Immunopathol; 1978 Jan; 9(1):63-6. PubMed ID: 618411
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: Measles and multiple sclerosis.
    Lancet; 1974 Feb; 1(7851):247-9. PubMed ID: 4130251
    [No Abstract]   [Full Text] [Related]  

  • 40. [Measles cellular immunity in patients with multiple sclerosis].
    Atanadze SN; Kodkind GKh; Smirnov YuK ; Khomak VIa; Veĭn AM
    Vopr Virusol; 1980; (2):166-9. PubMed ID: 6992452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.